Supplementary Figure 2
figure
posted on 2021-04-17, 06:51 authored by Sare Betul Kaygusuz, Esra Arslan Ates, Maria Lillina Vignola, Burcu Volkan, Bilgen Bilge Geckinli, Serap Turan, Abdullah Bereket, Carles Gaston-Massuet, Tulay Guran
Supplementary Figure 2: Continuous glucose monitoring (CGM) data of patient 2 after initiation of sulfonylurea.
The iPRO device (IPRO Professional CGM, Medtronic, USA was used for CGM along with regular SMBG. The CGM device was inserted subcutaneously by a trained employee of Medtronic Inc. CARELINK™ iPRO therapy management software for diabetes was used to upload CGM data and generate reports.
